Emmanuel Chorianopoulos, MD

Successful Transfemoral Antegrade Valve-in-Valve Implantation of a SAPIEN XT Valve into a Degenerated Mitral Valve Prosthesis

03/26/2012

Emmanuel Chorianopoulos , MD;

Hugo A. Katus , MD;

Raffi Bekeredjian , MD;

Abstract: Transfemoral aortic valve implantation has become an important interventional technique for patients with severe aortic stenosis and high surgical risks. The mitral valve has been a much greater challenge for interventional...

Abstract: Transfemoral aortic...

03/26/2012

Journal of Invasive Cardiology

Original Contribution

Percutaneous Edge-to-Edge Repair of Mitral Regurgitation as a Bail-Out Strategy in Critically Ill Patients

01/29/2013

Ulrike Krumsdorf , MD;

Emmanuel Chorianopoulos , MD;

Sven T. Pleger , MD;

Hugo A. Katus , MD;

Raffi Bekeredjian , MD;

Percutaneous edge-to-edge mitral valve repair using the MitraClip device has evolved as a new tool for the treatment of severe mitral valve regurgitation. This technique has been evaluated both in surgical low and high risk patients. The aim...

Percutaneous edge-to-edge mitral...

01/29/2013

Journal of Invasive Cardiology

Original Contribution

The Extent of Aortic Annulus Calcification is a Predictor of Postprocedural Eccentricity and Paravalvular Regurgitation: A Pre- and Postinterventional Cardiac Computed Tomography Angiography Study

02/24/2015

Grigorios Korosoglou , MD;

Emmanuel Chorianopoulos , MD;

Sven T. Pleger , MD;

Hugo A. Katus , MD;

Raffi Bekeredjian , MD;

Dorothea Bodingbauer , MD;

Nina P. Hofmann , MD;

Sebastian Greiner , MD;

Moritz Schuetz , MD;

Nicolas A. Geis , MD;

Hans U. Kauczor , MD;

Mark Bryant , MD;

Derliz Mereles , MD;

This study investigates whether the extent of aortic valve calcification is associated with postprocedural prosthesis eccentricity and paravalvular regurgitation in patients undergoing transcatheter aortic valve implantation.

This study investigates whether...

02/24/2015

Journal of Invasive Cardiology

Original Contribution

Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System

11/15/2016

Hugo A. Katus , MD;

Raffi Bekeredjian , MD;

Kai-Uwe Jarr , MD;

Florian Leuschner , MD;

Benjamin Meder , MD;

Emmanuel Chorianopoulos , MD;

An analysis of our first real-world experience with the second-generation, mechanically expanded, fully repositionable transfemoral Lotus TAVR device (Boston Scientific).

An analysis of our first...

11/15/2016

Journal of Invasive Cardiology

C-Reactive Protein Kinetics and its Prognostic Value After Transfemoral Aortic Valve Implantation

05/29/2012

Ulrike Krumsdorf , MD;

Emmanuel Chorianopoulos , MD;

Sven T. Pleger , MD;

Klaus Kallenbach , MD;

Matthias Karck , MD;

Hugo A. Katus , MD;

Raffi Bekeredjian , MD;

Abstract: Transcatheter aortic valve implantation (TAVI) has become an established therapeutic option in high-risk patients with severe aortic valve stenosis. The potential threat of a postinterventional infection is one of several...

Abstract: Transcatheter aortic...

05/29/2012

Journal of Invasive Cardiology